These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32277158)

  • 1. Role of a Concentration Gradient in Malaria Drug Resistance Evolution: A Combined within- and between-Hosts Modelling Approach.
    Romphosri S; Changruenngam S; Chookajorn T; Modchang C
    Sci Rep; 2020 Apr; 10(1):6219. PubMed ID: 32277158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic strain diversity predicts different biogeographic patterns of maintenance and decline of antimalarial drug resistance.
    He Q; Chaillet JK; Labbé F
    Elife; 2024 Feb; 12():. PubMed ID: 38363295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Rare, the Best: Spread of Antimalarial-Resistant Plasmodium falciparum Parasites by
    Berry A; Menard S; Nsango SE; Abate L; Concordet D; Tchioffo Tsapi M; Iriart X; Awono-Ambéné PH; Roche B; Morlais I
    Microbiol Spectr; 2021 Oct; 9(2):e0085221. PubMed ID: 34668767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A population genetic model for the initial spread of partially resistant malaria parasites under anti-malarial combination therapy and weak intrahost competition.
    Kim Y; Escalante AA; Schneider KA
    PLoS One; 2014; 9(7):e101601. PubMed ID: 25007207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local emergence in Amazonia of
    Mathieu LC; Cox H; Early AM; Mok S; Lazrek Y; Paquet JC; Ade MP; Lucchi NW; Grant Q; Udhayakumar V; Alexandre JS; Demar M; Ringwald P; Neafsey DE; Fidock DA; Musset L
    Elife; 2020 May; 9():. PubMed ID: 32394893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of heterogeneous transmission on the establishment and spread of antimalarial drug resistance.
    Klein EY
    J Theor Biol; 2014 Jan; 340():177-85. PubMed ID: 24076451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evolution of drug-resistant malaria: the role of drug elimination half-life.
    Hastings IM; Watkins WM; White NJ
    Philos Trans R Soc Lond B Biol Sci; 2002 Apr; 357(1420):505-19. PubMed ID: 12028788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized feasibility trial comparing four antimalarial drug regimens to induce
    Reuling IJ; van de Schans LA; Coffeng LE; Lanke K; Meerstein-Kessel L; Graumans W; van Gemert GJ; Teelen K; Siebelink-Stoter R; van de Vegte-Bolmer M; de Mast Q; van der Ven AJ; Ivinson K; Hermsen CC; de Vlas S; Bradley J; Collins KA; Ockenhouse CF; McCarthy J; Sauerwein RW; Bousema T
    Elife; 2018 Feb; 7():. PubMed ID: 29482720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The de novo selection of drug-resistant malaria parasites.
    White NJ; Pongtavornpinyo W
    Proc Biol Sci; 2003 Mar; 270(1514):545-54. PubMed ID: 12641911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinically immune hosts as a refuge for drug-sensitive malaria parasites.
    Klein EY; Smith DL; Boni MF; Laxminarayan R
    Malar J; 2008 Apr; 7():67. PubMed ID: 18439283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insight into molecular diagnosis for antimalarial drug resistance of Plasmodium falciparum parasites: A review.
    Zhong A; Zhang H; Li J
    Acta Trop; 2023 May; 241():106870. PubMed ID: 36849091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of resistance of Plasmodium falciparum to antimalarial drugs.
    Hyde JE
    Microbes Infect; 2002 Feb; 4(2):165-74. PubMed ID: 11880048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring resistant-genotype transmission of malaria parasites: challenges and prospects.
    Abdul-Ghani R; Farag HF; Allam AF; Azazy AA
    Parasitol Res; 2014 Apr; 113(4):1481-7. PubMed ID: 24562760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The resistome and genomic reconnaissance in the age of malaria elimination.
    Kümpornsin K; Kochakarn T; Chookajorn T
    Dis Model Mech; 2019 Dec; 12(12):. PubMed ID: 31874839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approximations for the hitchhiking effect caused by the evolution of antimalarial-drug resistance.
    Schneider KA; Kim Y
    J Math Biol; 2011 Jun; 62(6):789-832. PubMed ID: 20623287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The genomic architecture of antimalarial drug resistance.
    Cowell AN; Winzeler EA
    Brief Funct Genomics; 2019 Sep; 18(5):314-328. PubMed ID: 31119263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The activities of current antimalarial drugs on the life cycle stages of Plasmodium: a comparative study with human and rodent parasites.
    Delves M; Plouffe D; Scheurer C; Meister S; Wittlin S; Winzeler EA; Sinden RE; Leroy D
    PLoS Med; 2012 Feb; 9(2):e1001169. PubMed ID: 22363211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dynamics of mutations associated with anti-malarial drug resistance in Plasmodium falciparum.
    Escalante AA; Smith DL; Kim Y
    Trends Parasitol; 2009 Dec; 25(12):557-63. PubMed ID: 19864183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of Ugandan Plasmodium falciparum Isolates to the Antimalarial Drug Pipeline.
    Kreutzfeld O; Tumwebaze PK; Okitwi M; Orena S; Byaruhanga O; Katairo T; Conrad MD; Rasmussen SA; Legac J; Aydemir O; Giesbrecht D; Forte B; Campbell P; Smith A; Kano H; Nsobya SL; Blasco B; Duffey M; Bailey JA; Cooper RA; Rosenthal PJ
    Microbiol Spectr; 2023 Jun; 11(3):e0523622. PubMed ID: 37158739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.